HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.

AbstractOBJECTIVE:
Coronary heart disease is associated with monocytosis. Studies using animal models of monocytosis and atherosclerosis such as ApoE(-/-) mice have shown bone marrow (BM) hematopoietic stem and multipotential progenitor cell (HSPC) expansion, associated with increased cell surface expression of the common β subunit of the granulocyte macrophage colony-stimulating factor/interleukin-3 receptor (CBS) on HSPCs. ApoE(-/-) mice also display increased granulocyte macrophage colony-stimulating factor-dependent monocyte production in the spleen. We investigated the role of the CBS in cholesterol-driven HSPC expansion, monocytosis, and atherosclerosis.
APPROACH AND RESULTS:
Ldlr(-/-) mice were transplanted with ApoE(-/-)Cbs(-/-) or ApoE(-/-) BM followed by Western-type diet feeding. Compared with ApoE(-/-) BM-transplanted controls, ApoE(-/-)Cbs(-/-) BM-transplanted mice had reduced BM and splenic HSPC proliferation, fewer blood monocytes and neutrophils, and reduced macrophage content and area of early atherosclerotic lesions. More advanced lesions showed diminished macrophage and collagen content; however, lesion size was unchanged, reflecting an increase in necrotic core area, associated with a marked decrease in Abcg1 expression and increased macrophage apoptosis. Compared with wild-type mice, Western-type diet-fed ApoE(-/-) mice showed increased CBS expression on granulocyte macrophage colony-stimulating factor-producing innate response activator B cells and expansion of this population. ApoE(-/-)Cbs(-/-) BM-transplanted Ldlr(-/-) mice showed a marked decrease in innate response activator B cells compared with ApoE(-/-) BM-transplanted Ldlr(-/-) controls.
CONCLUSIONS:
Increased levels of CBS on HSPCs and splenic innate response activator B cells lead to expansion of these populations in ApoE(-/-) BM-transplanted Ldlr(-/-) mice, contributing to monocytosis and increased lesional macrophage content. However, in more advanced lesions, the CBS also has a role in atherosclerotic plaque stabilization.
AuthorsMi Wang, Manikandan Subramanian, Sandra Abramowicz, Andrew J Murphy, Ayelet Gonen, Joseph Witztum, Carrie Welch, Ira Tabas, Marit Westerterp, Alan R Tall
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 34 Issue 5 Pg. 976-84 (May 2014) ISSN: 1524-4636 [Electronic] United States
PMID24651678 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCG1 protein, mouse
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters
  • Apolipoproteins E
  • Cytokine Receptor Common beta Subunit
  • Lipoproteins
  • Receptors, LDL
Topics
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters (metabolism)
  • Animals
  • Aortic Diseases (genetics, metabolism, pathology)
  • Apolipoproteins E (deficiency, genetics)
  • Atherosclerosis (genetics, metabolism, pathology)
  • B-Lymphocytes (metabolism, pathology)
  • Bone Marrow Cells (metabolism, pathology)
  • Bone Marrow Transplantation
  • Cell Differentiation
  • Cell Proliferation
  • Cytokine Receptor Common beta Subunit (deficiency, genetics, metabolism)
  • Disease Models, Animal
  • Disease Progression
  • Hematopoietic Stem Cells (metabolism, pathology)
  • Immunity, Innate
  • Lipoproteins (metabolism)
  • Macrophages (metabolism, pathology)
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes (metabolism, pathology)
  • Necrosis
  • Plaque, Atherosclerotic
  • Receptors, LDL (deficiency, genetics)
  • Signal Transduction
  • Spleen (metabolism, pathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: